EUVIMEDEUVIMED entdecken
Crossref

Discovery of LLC355 as an Autophagy-Tethering Compound for the Degradation of Discoidin Domain Receptor 1

Lianchao Liu, Lijie Zhao, Lujun Yang, Minxue Chai, Zhengyong Liu, Nan Ma iD, Yongxing Wang, Qinxue Wu, Jing Guo, Fengtao Zhou iD, Weixue Huang, Xiaomei Ren und 4 weitere

Journal of Medicinal Chemistry · 2024

DOI: 10.1021/acs.jmedchem.4c00162 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Medicinal Chemistry, 2024. Verfasst von Lianchao Liu und 15 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Chemical Biology, Shanghai Institute of Organic Chemistry, Chinese Academy of Sciences, #345 Lingling Road, Shanghai 200032, …. Hauptthemen laut MEDLINE: Discoidin Domain Receptor 1, Autophagy. Die Arbeit wurde bisher 16-mal zitiert (Crossref) und nennt 37 Literaturangaben. Gefördert von: Shenzhen Bay Laboratory, Shanghai Key Laboratory of Chemical Biology, Science and Technology Commission of Shanghai Municipality.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Discoidin domain receptor 1 (DDR1) is a potential target for cancer drug discovery. Although several DDR1 kinase inhibitors have been developed, recent studies have revealed the critical roles of the noncatalytic functions of DDR1 in tumor progression, metastasis, and immune exclusion. Degradation of DDR1 presents an opportunity to block its noncatalytic functions. Here, we report the discovery of the DDR1 degrader LLC355 by employing autophagosome-tethering compound technology. Compound LLC355 efficiently degraded DDR1 protein with a DC50 value of 150.8 nM in non-small cell lung cancer NCI-H23 cells. Mechanistic studies revealed compound LLC355 to induce DDR1 degradation via lysosome-mediated autophagy. Importantly, compound LLC355 potently suppressed cancer cell tumorigenicity, migration, and invasion and significantly outperformed the corresponding inhibitor 1. These results underline the therapeutic advantage of targeting the noncatalytic function of DDR1 over inhibition of its kinase activity.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Discoidin Domain Receptor 1AutophagyHumansCell Line, TumorAntineoplastic AgentsAnimalsDrug DiscoveryCell MovementProteolysisStructure-Activity RelationshipLung NeoplasmsProtein Kinase InhibitorsCell ProliferationCarcinoma, Non-Small-Cell Lung

Substanzen

Discoidin Domain Receptor 1DDR1 protein, humanAntineoplastic AgentsProtein Kinase Inhibitors

Autor:innen und Institutionen

  • State Key Laboratory of Chemical Biology, Shanghai Institute of Organic Chemistry, Chinese Academy of Sciences, #345 Lingling Road, Shanghai 200032, China.
  • School of Molecular Medicine, Hangzhou Institute for Advanced Study, University of Chinese Academy of Sciences, #1 Xiangshan Branch Lane, Hangzhou 310024, China.
  • Hangzhou Institute of Medicine (HIM), Chinese Academy of Sciences, Hangzhou, Zhejiang 310022, China.
  • College of Chemistry and Materials Science, Anhui Normal University, 189 South Jiuhua Road, Wuhu, Anhui 241002, China.
  • International Cooperative Laboratory of Traditional Chinese Medicine Modernization and Innovative Drug Discovery of Chinese Ministry of Education (MOE), Guangzhou City Key Laboratory of Precision Chemical Drug Developme…
  • Livzon Research Institute, Livzon Pharmaceutical Group Inc., #38 Chuangye North Road, Jinwan District, Zhuhai 519000, China.

ORCID-Profile: Nan Ma, Fengtao Zhou, Jian Wang, Zhen Wang, Ke Ding

Förderung

  • Shenzhen Bay Laboratory
  • Shanghai Key Laboratory of Chemical Biology
  • Science and Technology Commission of Shanghai Municipality
  • National Natural Science Foundation of China
  • Livzon Pharmaceutical Group Inc.

Zitieren

APA

Liu, L., Zhao, L., Yang, L., Chai, M., Liu, Z., Ma, N., Wang, Y., Wu, Q., Guo, J., Zhou, F., Huang, W., Ren, X., Wang, J., Ding, M., Wang, Z., & Ding, K. (2024). Discovery of LLC355 as an Autophagy-Tethering Compound for the Degradation of Discoidin Domain Receptor 1. Journal of Medicinal Chemistry. https://doi.org/10.1021/acs.jmedchem.4c00162

Vancouver

Liu L, Zhao L, Yang L, Chai M, Liu Z, Ma N, et al. Discovery of LLC355 as an Autophagy-Tethering Compound for the Degradation of Discoidin Domain Receptor 1. Journal of Medicinal Chemistry. 2024. doi:10.1021/acs.jmedchem.4c00162

BibTeX
@article{Liu2024,
  author = {Liu, Lianchao and Zhao, Lijie and Yang, Lujun and Chai, Minxue and Liu, Zhengyong and Ma, Nan and Wang, Yongxing and Wu, Qinxue and Guo, Jing and Zhou, Fengtao and Huang, Weixue and Ren, Xiaomei and Wang, Jian and Ding, Ming and Wang, Zhen and Ding, Ke},
  title = {Discovery of LLC355 as an Autophagy-Tethering Compound for the Degradation of Discoidin Domain Receptor 1},
  journal = {Journal of Medicinal Chemistry},
  year = {2024},
  doi = {10.1021/acs.jmedchem.4c00162}
}
Kostenlos starten →